Current strategies for high Lp(a) involve attacking apob and other cardiovascular risk factors, with new drugs in development to inhibit liver production of Lp(a).

“so up until i would say a few years ago the only strategy for patients let's assume that we've confirmed that a patient's lp little a is elevated and furthermore let's confirm that we have reason to believe that in that patient the lp little a is also problematic and again this usually shows up in family history it's not a subtle thing a lot of times i'm taking the family history from a patient before i've got the blood test that'll be there those could be offset by weeks and it's because we give our patients the template to work on this they come in with a very thorough family history they really know what happened to you know the mother's older sister and the grandfather and all of these other things and you know you usually just see this history of heart lots of heart attacks before the age of 60.”